Position in BCRX
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$149,416
New position
Shares Held
15,695
first reported quarter
Ownership
0.006%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026AVIVA PLC holds $184,196,374 across 6 Drug Manufacturers - Specialty & Generic names. BCRX ranks #6 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
968,672 | $114,506,717 | |
| 2 | TEVA |
Teva Pharmaceutical Industries Ltd
|
1,300,604 | $39,174,192 | |
| 3 | UTHR |
UNITED THERAPEUTICS Corp
|
34,451 | $20,428,753 | |
| 4 | NBIX |
Neurocrine Biosciences Inc
|
71,310 | $9,394,379 | |
| 5 | ALKS |
Alkermes plc.
|
15,354 | $542,917 | |
| 6 | BCRX |
Biocryst Pharmaceuticals Inc
This page
|
15,695 | $149,416 |
All Filings in BCRX
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $149,416 | 15,695 | Shares | Defined | 2026-05-14 | |
| No filing history on record for this holder in this stock. | ||||||